Skip to content
Health Systems Facts

Denmark: Pharmaceuticals

Danish Health System Overview
Health System Rankings
Health System Outcomes
Health System Coverage
Costs for Consumers
Health System Expenditures
Danish COVID-19 Policy

Health System Financing
Health System Personnel
Health System Physical Resources and Utilization
Long-Term Care
Health Information and Communications Technologies
Medical Training
Pharmaceuticals

Danish Political System
Economic System
Population Demographics
Health System History and Development
Health System Future Challenges


Expenditure On Retail Pharmaceuticals Per Capita, 2017 (USD$ PPP)
Prescribed Medicines: $212
Over-The-Counter Medicines: $52
Medical Non-Durable: $55
Total: $318

Source: OECD (2019), Health at a Glance 2019: OECD Indicators, OECD Publishing, Paris, https://doi.org/10.1787/4dd50c09-en.
https://www.oecd.org/health/health-systems/health-at-a-glance-19991312.htm


Expenditure On Retail Pharmaceuticals By Type Of Financing, 2017 (%)
Government/Compulsory Plans: 43%
Voluntary Health Insurance Plans: 6%
Out-Of-Pocket: 51%
Other: 0%

Source: OECD (2019), Health at a Glance 2019: OECD Indicators, OECD Publishing, Paris, https://doi.org/10.1787/4dd50c09-en.
https://www.oecd.org/health/health-systems/health-at-a-glance-19991312.htm


“Drugs prescribed at hospitals are free at the point of delivery, whereas drugs prescribed by GPs are subject to co-insurance. The degree of co-insurance depends on the individual patient’s drug costs in a year. If the individual patient’s costs do not exceed DKK 865 (€116), the patient does not receive a refund (although patients under 18 years of age will receive a refund of 60% of their drug costs); patients with drug costs of DKK 865 – 1410 (€116 – 189) receive a refund of 50% (patients below 18 years of age, 60%); patients with drug costs of DKK 1410 – 3045 (€189 – 408) receive a refund of 75% (independently of their age); and patients with drug costs above DKK 3045 (€408) receive a refund of 85%.

“Chronically ill patients with permanent or high drug utilization levels can apply for full reimbursement for any expenditure above an annual ceiling of DKK 3555 (€477). The municipalities may pay part of pensioners’ drug costs, the size of the share depending on the pensioner’s capital. Pensioners who find it difficult to pay for pharmaceuticals can apply to their municipality for financial assistance. Patients with very low income can receive partial reimbursement, on a case-by-case basis. In addition, many individuals purchase VHI to spread the risk of high drug costs and level out the cost of drugs prescribed outside hospitals over time.

“Pharmacies are required to substitute the least expensive generic drug for the drug prescribed by the GP to reduce drug costs for the public sector as well as for the individual patient.

“Out-of-pocket payments are not tax deductible. Limits to costs in drugs but not in other areas (dentistry and other providers outside hospitals) means that user charges in some areas have consequences for individual patients and for equality (see sections 3.7, 7.2 and 7.3.2).”

Source: Olejaz M, Juul Nielsen A, Rudkjøbing A, Okkels Birk H, Krasnik A,
Hernández-Quevedo C. Denmark: Health system review. Health Systems
in Transition, 2012, 14(2):1 – 192.
https://www.euro.who.int/en/about-us/partners/observatory/publications/health-system-reviews-hits/full-list-of-country-hits
https://www.euro.who.int/en/about-us/partners/observatory/publications/health-system-reviews-hits/full-list-of-country-hits/denmark-hit-2012


Health Systems Facts is a project of the Real Reporting Foundation. We provide reliable statistics and other data from authoritative sources regarding health systems in the US and several other nations.


Page last updated Dec. 29, 2020 by Doug McVay, Editor.

  • Home
  • About Health Systems Facts
    • Contact Us
    • Join Our Email List
  • US Health System Facts
  • Comparing National Health Systems
  • Foreign Health Systems
    • Austria
    • Canada
    • Costa Rica
    • Czech Republic
    • Denmark
    • France
    • Germany
    • Italy
    • Japan
    • Netherlands
    • South Korea
    • Spain
    • Sweden
    • Switzerland
    • United Kingdom
  • Health System Outcomes
  • Information and Communications Technologies
  • Long-Term Care
  • Medical Workforce Training
  • Pharmaceutical Pricing and Regulation
  • Various US Health System Proposals
    • ACA Innovations
    • All Payer
    • Health Information and Communication Technologies
    • Public Option
    • Single Payer / “Medicare For All”
    • Universal Health Coverage
    • Examining Health System Proposals
  • Recommended Resources
  • COVID19 National Strategies
    • Austria
    • Canada
    • Czech Republic
    • Denmark
    • France
    • Germany
    • Italy
    • Japan
    • Netherlands
    • South Korea
    • Spain
    • Sweden
    • Switzerland
    • United Kingdom
  • Privacy Policy

Follow Us On Social Media!


© 2019-2020 Real Reporting Foundation | Theme by WordPress Theme Detector